Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: Distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma

Journal of Clinical Pathology

Volumn 59, Issue 7, 2006, Pages 711-715

  Muirhead, D M ^a   Hoffman, H T ^a   Robinson, R A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KERATIN; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINIZATION; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATINS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM STAGING; RETINOBLASTOMA PROTEIN; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33745887525     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.030502     Document Type: Article

References (19)

1. Wing Yuen P, Man M, Yin Lam K, et al. Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. J Clin Pathol 2002;55:58-60.
2. American Joint Committee on Cancer. AJCC cancer staging manual. 6th edn. New York: Springer, 2000:23-32.
3. Meling GI, Lothe RA, Borresen AL, et al. Genetic alterations within the retinoblastoma locus in colorectal carcinoma. Relation to DNA ploidy pattern studies by flow cytometric analysis. Br J Cancer 1991;64:475-80.
4. Boyton RF, Huang Y, Blount PL, et al. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res 1991;51:5766-9.
5. Jiang W, Zhang YJ, Kahn SM, et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 1993;90:9026-30.
6. Pande P, Mathur M, Shukla NK, et al. pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncol 1998;34:396-403.
7. Geisler SA, Olshan AF, Weissler MC, et al. p16 and p53 protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 2002;8:3445-53.
8. Cairns P, Ploascik TJ, Eby Y, et al. Frequency of homozygous deletion at p16/cdkn2 in primary human tumors. Nat Genetics 1995;11:210-2.
9. Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTs1 in human cancers. Nat Med 1995;4:686-92.
10. Zhang SY, Klein-Szanto AJP, Sauter ER, et al. Higher frequency alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 1994;54:5050-3.
11. Andl T, Kahn T, Pfuhl A, et al. Etiological involvement of oncogenic human papilloma virus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998;58:5-13.
12. Lai S, El-Nagger AK. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas. Lab Invest 1999;79:255-60.
13. INK4A and cyclin D1 in tumorigenesis of oral squamous cell carcinomas. Cancer Lett 2000;160:3-8.
14. Li Y, Nichols MA, Shay JW, et al. Transcriptional repression of the D-type cyclin dependent kinase inhibitor p16 by retinoblastoma susceptibility gene product pRb. Cancer Res 1994;54:6078-82.
15. INK4 in human cancer. Proc Natl Acad Sci USA 1994;91:11045-9.
16. INK4a in oral premalignant lesions. Oncogene 1997;14:1799-803.
17. Todd R, Hinds PW, Munger K, et al. Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med 2002;13:51-61.
18. Tanaka N, Ogi K, Odajima T, et al. pRb/p130 protein expression is correlated with clinicopathologic findings in patients with oral squamous cell carcinoma. Cancer 2001;92:2117-25.
19. Tsai C, Yang C, Chou L, et al. The correlation between alteration of p16 gene and clinical status in oral squamous cell carcinoma. J Oral Pathol Med 2001;30:527-31.